The nuclear factor of activated T cells (NFAT) transcription factor NFATp (NFATc2) is a repressor of chondrogenesis

Journal of Experimental Medicine

Volumn 191, Issue 1, 2000, Pages 9-21

  Ranger, Ann M ^a   Gerstenfeld, Louis C ^d   Wang, Jinxi ^b   Kon, Tamiyo ^e   Bae, Hyunsu ^a   Gravallese, Ellen M ^c   Glimcher, Melvin J ^b   Glimcher, Laurie H ^a,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^e CHIBA UNIVERSITY   (Japan)

Author keywords

Cartilage; Chondrosarcoma; Differentiation; Mesenchymal stem cells; NFATp

Indexed keywords

NUCLEAR FACTOR; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CELL DIFFERENTIATION; CHONDROGENESIS; CONTROLLED STUDY; ENCHONDRAL OSSIFICATION; GENE EXPRESSION REGULATION; MESENCHYME; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPRESSOR GENE; STEM CELL; T LYMPHOCYTE ACTIVATION; TUMOR SUPPRESSOR GENE;

ANIMALS; BONE AND BONES; BONE DEVELOPMENT; CARTILAGE; CELL DIFFERENTIATION; CELL DIVISION; CHONDROGENESIS; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NFATC TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; STEM CELLS; TRANSCRIPTION FACTORS;

EID: 0034598356     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.191.1.9     Document Type: Article

References (78)

1. Durand, D., J. Shaw, M. Bush, R. Replogle, R. Belagaje, and G. Crabtree. 1988. Characterization of antigen receptor response elements within the interleukin-2 enhancer. Mol. Cell. Biol. 8:1715-1724.
2. Shaw, J., P. Utz, D. Durand, J. Toole, E. Emmel, and G. Crabtree. 1988. Identification of a putative regulator of early T cell activation genes. Science. 241:202-205.
3. Crabtree, G. 1989. Contingent genetic regulatory events in T lymphocyte activation. Science. 249:355-360.
4. Rao, A., C. Luo, and P.G. Hogan. 1997. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15:707-747.
5. Ranger, A.M., M.J. Grusby, M.R. Hodge, E.M. Gravallese, F.C. de la Brousse, T. Hoey, C. Mickanin, H.S. Baldwin, and L.H. Glimcher. 1998. The transcription factor NF-ATc is essential for cardiac valve formation. Nature. 392:186-190.
6. Luis de la Pompa, J., L.A. Timmerman, H. Takimoto, H. Yoshida, A.J. Elia, E. Samper, J. Potter, A. Wakeham, L. Marengere, B.L. Langille, et al. 1998. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature. 392:182-186.
7. Northrop, J.P., S.N. Ho, L. Chen, D.J. Thomas, L.A. Timmerman, G.P. Nolan, A. Admon, and G.R. Crabtree. 1994. NF-AT components define a family of transcription factors targeted in T-cell activation. Nature. 369:497-502.
8. McCaffrey, P.G., C. Luo, T.K. Kerppola, J. Jain, T.M. Badalian, A.M. Ho, E. Burgeon, W.S. Lane, J.N. Lambert, T. Curran, et al. 1993. Isolation ot the cyclosporin-sensitive T cell transcription factor NFATp. Science. 262:750-754.
9. Hoey, T., Y.-L. Sun, K. Williamson, and X. Xu. 1995. Isolation of two new members of the NF-AT gene family and functional characterization of the NF-AT proteins. Immunity. 2:461-472.
10. Masuda, E.S., Y. Naito, H. Tokumitsu, D. Campbell, F. Saito, C. Hannum, K.-i. Arai, and N. Arai. 1995. NFATx, a novel member ot the nuclear factor of activated T cells family that is expressed predominantly in the thymus. Mol. Cell. Biol. 15:2697-2706.
11. Ho, S.N., D.J. Thomas, L.A. Timmerman, X. Li, U. Francke, and G.R. Crabtree. 1995. NFATc3, a lymphoid-specific NFATc family member that is calcium-regulated and exhibits distinct DNA binding specificity. J. Biol. Chem. 270: 19898-19907.
12. Beals, C.R., N.A. Clipstone, S.N. Ho, and G.R. Crabtree. 1997. Nuclear localization of NF-ATc by a calcineurin-dependent, cyclosporin-sensitive intramolecular interaction. Genes Dev: 11:824-834.
13. Clipstone, N.A., and G.R. Crabtree. 1992. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature. 357:695-697.
14. Flanagan, W.M., B. Corthesy, R.J. Bram, and G.R. Crabtree. 1991. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature. 352:803-807.
15. Cockerill, P.N., M.F. Shannon, A.G., Bert, G.R. Ryan, and M.A. Vadas. 1993. The granulocyte-macrophage colony-stimulating factor/interleukin 3 locus is regulated by an inducible cyclosporin A-sensitive enhancer. Proc. Natl. Acad. Sci. USA. 90:2466-2470.
16. Rooney, J.W., T. Hoey, and L.H. Glimcher. 1995. Coordinate and cooperative roles tor NF-AT and AP-1 in the regulation of the murine IL-4 gene. Immunity. 2:545-553.
17. Ho, I.-C., M.R. Hodge, J.W. Rooney, and L.H. Glimcher. 1996. The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell. 85:973-983.
18. Hodge, M.R., H.J. Chun, J. Rengarajan, A. Alt, R. Lieberson, and L.H. Glimcher. 1996. NFAT-driven interleukin-4 transcription potentiated by NIP45. Science. 274:1903-1905.
19. Beals, C.R., C.M. Sheridan, C.W. Turck, P. Gardner, and G.R. Crabtree. 1997. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 275:1930-1933.
20. Emmel, E.A., C.L. Verweij, D.B. Durand, K.M. Higgins, E. Lacy, and G.R. Crabtree. 1989. Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation. Science. 246:1617-1620.
21. Molkentin, J.D. J.R. Lu, C.L. Antos, B. Markham, J. Richardson, J. Robbins, S.R. Grant, and E.N. Olson. 1998. A calcnieurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 93:215-228.
22. Ranger, A.M., M.R. Hodge, E.M. Gravallese, M. Oukka, L. Davidson, F.W. Alt, F.C. de la Brousse, T. Hoey, M. Grusby, and L.H. Glimcher. 1998. Delayed lymphoid repopulation with detects in IL-4-driven responses produced by inactivation of NFATc. Immunity. 8:125-134.
23. Yoshida, H., H. Nishina, H. Takimoto, L.E. Marengere, A.C. Wakeham, D. Bouchard, Y.Y. Kong, T. Ohteki, A. Shahinian, M. Bachmann, et al. 1998. The transcription factor NF-ATc1 regulates lymphocyte proliferation and Th2 cytokine production. Immunity. 8:115-124.
24. Kinoshita, S., L. Su, M. Amano, L.A. Timmerman, H. Kaneshima, and G.P. Nolan. 1997. The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells. Immunity. 6:235-244.
25. Oukka, M., I.-C. Ho, F.C. de la Brousse, T. Hoey, M.J. Grusby, and L.H. Glimcher. 1998. The transcription factor NFAT4 is involved in the generation and survival of T cells. Immunity. 9:295-304.
26. Hodge, M.R., A.M. Ranger, F.C. de la Brousse, T. Hoey, M.J. Grusby, and L.H. Glimcher. 1996. Hyperproliteration and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity. 4:1-20.
27. Xanthoudakis, S., J.P.B. Viola, K.T.Y. Shaw, C. Luo, J.D. Wallace, P.T. Bozza, D.C. Luk, T. Curran, and A. Rao. 1996. An enhanced immune response in mice lacking the transcription factor NFAT1. Science. 272:892-895.
28. Kiani, A., J.P.B. Viola, A.H. Lichtman, and A. Rao. 1997. Down-regulation of IL-4 gene transcription and control of Th2 cell differentiation by a mechanism involving NFAT1. Immunity. 7:849-860.
29. Ranger, A.M., M. Oukka, J. Rengarajan, and L.H. Glimcher. 1998. Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development. Immunity 9:627-635.
30. Ho. I.-C., J.H.-J. Kim, J.W. Rooney, B.M. Spiegelman, and L.H. Glimcher. 1998. A potential role for the nuclear factor of activated T cells family of transcriptional regulatory proteins in adipogenesis. Proc. Natl. Acad. USA. 95:15537-15541.
31. Abbott, K.L., B.B. Friday, D. Thaloor, T.J. Murphy, and G.K. Pavlath. 1998. Activation and cellular localization of the cyclosporine A-sensitive transcription factor NF-AT in skeletal muscle cells. Mol. Biol. Cell. 10:2905-2916.
32. Clauss, I.M., E.M. Gravallese, J.M. Darling, F. Shapiro, M.J. Glimcher, and L.H. Glimcher. 1993. In situ hybridization studies suggest a role for the basic region-leucine zipper protein hXBP-1 in exocrine gland and skeletal development during mouse embryogenesis. Dev. Dyn. 197:146-156.
33. Gerstenfeld, L.C., M.H. Finer, and H. Boedtker. 1989. Quantitative analysis of collagen expression in embryonic chick chondrocytes having different developmental fates. J. Biol. Chem. 264:5112-5126.
34. Toma, C., J. Schaffer, M.C. Meazzini, D. Zurakowski, H.-D. Nah, and L.C. Gerstenfeld. 1997. Developmental restriction of embryonic mesenchymal stem cells as characterized by their in vitro potential for differentiation. J. Botte Miner. Res. 12:2024-2039.
35. Metsaranta, M., D. Toman, B. deCrombrugghe, and E. Vuorio. 1991. Specific hybridization probes for mouse type I, II, III and IX collagen mRNAs. Biochem. Biophys. Acta. 1089:241-243.
36. Elima, K., I. Eerola, R. Rosati, M. Metsaranta, S. Garofalo, M. Perala, B. deCrombrugghe, and E. Vuorio. 1993. The mouse collagen X gene: complete nucleotide sequence, exon structure and expression pattern. Biochem. J. 289:247-253.
37. Chang, S.C., B. Hoang, J.T. Thomas, S. Vukicevic, F.P. Luyten, N.J. Ryba, C.A. Kozak, A.H. Reddi, and M. Moos. 1994. Cartilage-derived morphogenetic proteins. New members of the transforming growth factor-beta superfamily predominantly expressed in long bones during human embryonic development. J. Biol. Chem. 45:28227-28234.
38. 2+ response amplitude and duration. Nature. 386:855-858.
39. Lennon, D.P., S.E. Haynesworth, S.P. Bruder, N. Jaiswal, and A.I. Caplan. 1996. Human and animal mesenchymal progenitor cells from bone marrow: identification of serum for optimal selection and proliferation. In Vitro Cell. Dev. Biol. 32:602-611.
40. Pittenger, M.F., A.M. Mackay, S.C. Beck, R.K. Jaiswal, K. Douglas, J.D. Mosca, M.A. Moorman, D.W. Simonetti, S. Craig, and D.R. Marshak. 1999. Multilineage potential of adult human mesenchymal stem cells. Science. 284:143-147.
41. Mackay, A.M., S.C. Beck, J.M. Murphy, F.P. Barry, C.O. Chichester, and M.F. Pittenger. 1998. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng. 4:415-1-27.
42. Dennis, J.E., A. Merriam, A. Awadallah, J.U. Yoo, B. Johnstone, and A.I. Caplan. 1999. A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J. Bone Miner. Res. 14:700-709.
43. Johnstone, B., T.M. Hering, A.I. Caplan, V.M. Goldberg, and J.U. Yoo. 1998. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells, Exp. Cell Res. 238:265-272.
44. b-tsA58 transgenic mouse. J. Cell. Physiol. 167:523-538.
45. Yoo, J.U., T.S. Barthel, K. Nishimura, L. Solchaga, A.I. Caplan, V.M. Goldberg, and B. Johnstone. 1998. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J. Bone Joint Surg. Am. 80:1745-1757.
46. Wozney, J.M., V. Rosen, A.J. Celeste, L.M. Mitsock, M.J. Whitters, R.W. Kriz, R.M. Hewick, and E.A. Wang. 1988. Novel regulators of bone formation: molecular clones and activities. Science. 242:1528-1534.
47. Kingsley, D.M. 1994. The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8:133-146.
48. Zhou, G., V. Lefebvre, Z. Zhang, H. Eberspaecher, and B. deCrombrugghe. 1998. Three high mobility group-like sequences within a 48-base pair enhancer of the Col2α1 gene are required for cartilage-specific expression in vivo. J. Biol. Chem. 273:14989-14997.
49. Meyer, J., P. Sudbeck, M. Held, T. Wagner, M.L. Schmitz, F.D. Bricarelli, E. Eggermont, U. Friedrich, O.A. Haas, A. Kobelt, et al. 1997. Mutational analysis of the SOX9 gene in campomelic dysplasia and autosomal sex reversal: lack of genotype/phenotype correlations. Hum. Mol. Genet. 6:91-98.
50. Wunderle, V.M., R. Critcher, N. Hastie, P.N. Goodfellow, and A. Schedl. 1998. Deletion of long-range regulatory elements upstream of SOX9 causes campomelic dysplasia and autosomal sex reversal: lack of genotype/phenotype correlations. Proc. Natl. Acad. Sci. USA. 95:10649-10654.
51. Caplan, A.I. 1988. Bone development, Ciba Found. Symp. 136:3-21.
52. Erlebacher, A., E.H. Filvaroff, S.E. Gitelman, and R. Derynck. 1995. Toward a molecular understanding of skeletal development. Cell. 80:371-378.
53. Poole, A.R. 1991. The growth plate: cellular physiology, cartilage assembly and mineralization. In Cartilage: Molecular Aspects. B.K. Hall and S.A. Newman, editors. CKC Press, Boca Raton, FL. 179-211.
54. Vortkamp, A., K. Lee, B. Lanske, G.V. Segre, H.M. Kronenberg, and C.J. Tabin. 1996. Regulation of rate of cartilage differentiation by indian hedgehog and PTH-related protein. Science. 273:613-622.
55. Bitgood, M.J., and A.P. McMahon. 1995. Hedgehog and Bmp genes are coexpressed at many diverse sites of cell-cell interaction in the mouse embryo. Dev. Biol. 172:126-138.
56. Karaplis, A.C., A. Luz, J. Glowacki, R.T. Bronson, V.L. Tybulewicz, H.M. Kronenberg, and R.C. Mulligan. 1994. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev. 8:277-289.
57. Chung, U., B. Lanske, K. Lee, E. Li, and H. Kronenberg. 1998. The parathyroid hormone/parathyroid hormone-related peptide receptor coordinates endochondral bone development by directly controlling chondrocyte differentiation. Proc. Natl. Acad. Sci. USA. 95:13030-13035.
58. Deng, C., A. Wynshaw-Boris, F. Zhou, A. Kuo, and P. Leder. 1996. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell. 84:911-921.
59. Rousseau, F., J. Bonaventure, L. Legeai-Mallet, A. Pelet, J.M. Rozet, P. Maroteaux, M. Le M errer, and A. Munnich. 1994. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature. 371:252-254.
60. Shiang, R., L.M. Thompson, Y.Z. Zhu, D.M. Church, T.J. Fielder, M. Bocian, S.T. Winokur, and J.J. Wasmuth. 1994. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell. 78:335-342.
61. Baker, J., J.P. Liu, E.J. Robertson, and A. Efstratiadis. 1993. Role of insulin-like growth factors in embryonic and postnatal growth. Cell. 75:73-82.
62. Brunet, L.J., J.A. McMahon, A.P. McMahon, and R.M Harland. 1998. Noggin, cartilage morphogenesis and joint formation in the mammalian skeleton. Science. 280:1455-1457.
63. Vukicevic, S., F.P. Luyten, and A.H. Reddi. 1989. Stimulation of the expression of osteogenic and chondrogenic phenotypes in vitro by osteogenin. Proc. Natl. Acad. Sci. USA. 86: 8793-8797.
64. Erlacher, L., J. McCartney, E. Piek, P.T. Dijke, M. Yanagishita, H. Oppermann, and F.P. Luyten. 1998. Cartilage-derived morphogenetic proteins and osteogenic protein-1 differentially regulate osteogenesis. J. Bone Miner. Res. 13:383-392.
65. Chang, S.C., B. Hoang, J.T. Thomas, S. Vukicevic, F.P. Luyten, N.J.P. Ryba, C.A. Kozak, A.H. Reddi, and M. Moos, Jr. 1994. Cartilage-derived morphogenetic proteins. J. Biol. Chem. 269:28227-28234.
66. Joyce, M.E., A.B. Roberts, M.B. Sporn, and M.E. Bolander. 1990. Transforming growth factor-β and the initiation of chondrogenesis and osteogenesis in the rat femur. J. Cell Biol. 110:2195-2207.
67. Storm, E.E., T.V. Huynh, N.G. Copeland, N.A. Jenkins, D.M. Kingsley, and S.-J. Lee. 1994. Limb alterations in brachypodism mice due to mutations in a new member of the TGFβ-superfamily. Nature. 368:639-643.
68. Brown, C.B., A.S. Boyer, R.B. Runyan, and J.V. Barnett. 1999. Requirement of type III TGF-β receptor for endocardial cell transformation in the heart. Science. 283:2080-2082.
69. b-tsA58 transgenic mouse. Proc. Natl. Acad. Sci. USA. 88:5096-5100.
70. Lee, F.Y., H.J. Mankin, G. Fondren, M.C. Gebhardt, D.S. Springfield, A.E. Rosenberg, and L.C. Jennings. 1999. Chondrosarcoma of bone: an assessment of outcome. J. Bone Joint Surg. 81:326-338.
71. Enneking, W.F. 1986. A system of staging musculoskeletal neoplasms. Clin. Orthop. 204:9-24.
72. Helio, H., E. Karaharju, T. Bohling, A. Kivioja, and S. Nordling. 1995. Chondrosarcoma of bone. A clinical and DNA flow cytometric study. Eur. J. Surg. Oncol. 21:408-413.
73. Kreicbergs, A., G. Soderberg, and A. Zetterberg. 1980. The prognostic significance of nuclear DNA content in chondrosarcoma. Anal. Quant. Cytol. 4:272-279.
74. Sandberg, A.A., and J.A. Bridge. 1994. The Cytogenetics of Bone and Soft Tissue Tumors, R.G. Landes Company, Austin, TX. 469 pp.
75. Raskind, W.H., E.U. Conrad, H. Chansky, and M. Matsushita. 1995. Loss of heterozygosity in chondrosarcomas for markers linked to hereditary multiple exostoses loci on chromosomes 8 and 11. Am. J. Hum. Genet. 56:1132-1139.
76. Friend, S.H., R. Bernards, S. Rogelj, R.A. Weinberg, J. Rapaport, D.M. Albert, and T.P. Dryja. 1986. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature. 323:643-646.
77. Dobashi, Y., H. Sugimura, A. Sato, T. Hirabayashi, H. Kanda, T. Kitagawa, N. Kawaguchi, T. Imamura, and R. Machinami. 1993. Possible association of p53 overexpression and mutation with high-grade chondrosarcoma. Diagn. Mol. Pathol. 2:257-263.
78. Wadayama, B., J. Toguchida, T. Yamaguchi, M.S. Sasaki, Y. Kotoura, and T. Yamamuro. 1993. p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas. Br. J. Cancer. 68:1134-1139.